Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,365,411
+$4,950,955 QoQ
Shares Held
649,980
-8.3% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#60
of 751 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SYSTEMATIC FINANCIAL MANAGEMENT LP holds $199,582,267 across 6 Biotechnology names. EXEL ranks #3 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
378,715 | $91,258,952 | |
| 2 | INVA |
Innoviva, Inc.
|
2,023,565 | $45,955,160 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
649,980 | $35,365,411 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
290,249 | $16,608,047 | |
| 5 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
1,665,817 | $10,394,697 | |
| 6 | 667,883 | $0 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,365,411 | 649,980 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $30,414,456 | 709,127 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $43,273,796 | 987,310 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $45,233,659 | 1,095,246 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $49,176,484 | 1,115,619 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $41,837,817 | 1,133,202 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $38,771,755 | 1,164,317 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $30,319,746 | 1,168,391 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $24,510,096 | 1,090,792 | Shares | Other | 2024-08-16 | |
| 2024-03-31 | $26,844,822 | 1,131,261 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $27,236,110 | 1,135,311 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $25,167,223 | 1,151,818 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $22,392,103 | 1,171,748 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $23,596,833 | 1,215,705 | Shares | Other | 2023-05-12 | |
| 2022-12-31 | $19,427,423 | 1,211,186 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $18,533,744 | 1,181,999 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,752,835 | 1,188,897 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $26,135,857 | 1,152,883 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $19,994,590 | 1,093,796 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $23,606,023 | 1,116,652 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $19,027,619 | 1,044,326 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $18,294,714 | 809,859 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $13,074,942 | 651,467 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $11,591,353 | 474,084 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $9,307,053 | 392,041 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||